| Drugs with this side effect as MedDRA Preferred Term
			
			
	  	Enfuvirtide
				
				
					Disturbance in attention: 1.9% - 2.3% Insulin
				
			K779
				
				
					Cerebration impaired: 1% - 21% MDV3100
				
			NovoLog
				
			Sativex
				
			acetaminophen
				
				
					Disturbance in attention: common almotriptan
				
				
					Cerebration impaired: rare alprazolam
				
				
					Disturbance in attention: 3.2% Cerebration impairedamantadine
				
				
					Cerebration impaired: common amitriptyline
				
			amoxapine
				
			amphetamine
				
			aripiprazole
				
				
					Disturbance in attention: 1% - 3% Cerebration impairedbetaxolol
				
			boceprevir
				
				
					Disturbance in attention: common bortezomib
				
			bosentan
				
			buprenorphine
				
				
					Disturbance in attentionCerebration impairedbupropion
				
				
					Disturbance in attentionCerebration impaired: 3% - 9% Impairment of attention: rare cabergoline
				
			cabozantinib
				
			carvedilol
				
			cefpodoxime
				
			cetirizine
				
			chlorpheniramine
				
			ciprofloxacin
				
			citalopram
				
				
					Cerebration impaired: uncommon, frequent Disturbance in attention: infrequent clomipramine
				
				
					Disturbance in attentionCerebration impaired: common, 5% clonazepam
				
			cyclobenzaprine
				
				
					Disturbance in attention: 6% Cerebration impaireddarunavir
				
			delavirdine
				
			desmopressin
				
			desvenlafaxine
				
				
					Disturbance in attention: 1% - 2% diazepam
				
			diclofenac
				
			dihydroergotamine
				
				
					Cerebration impaired: infrequent dothiepin
				
			doxazosin
				
			doxepin
				
				
					Disturbance in attention: rare Cerebration impairedduloxetine
				
				
					Disturbance in attention: postmarketing, infrequent, uncommon efavirenz
				
				
					Disturbance in attention: common, 3.6% Cerebration impaired: 0% - 9% entacapone
				
			eslicarbazepine acetate
				
			ethosuximide
				
			etravirine
				
			felbamate
				
			fentanyl
				
				
					Disturbance in attentionCerebration impairedfluoxetine
				
				
					Disturbance in attentionCerebration impairedfrovatriptan
				
				
					Cerebration impaired: infrequent furosemide
				
			gliclazide
				
				
					Poor concentrationCerebration impairedglimepiride
				
			hydromorphone
				
			hydroxybutyrate
				
				
					Disturbance in attention: 0% - 4% insulin detemir
				
			isomannide
				
			isosorbide-5-mononitrate
				
			ketorolac
				
			ketorolac tromethamine
				
				
					Cerebration impaired: postmarketing lacosamide
				
			levetiracetam
				
				
					Disturbance in attention: common lomefloxacin
				
			lorcaserin
				
			lormetazepam
				
			melatonin
				
			memantine
				
			metoprolol
				
				
					Cerebration impaired: uncommon mirtazapine
				
				
					Cerebration impaired: postmarketing modafinil
				
				
					Disturbance in attention: 1% montelukast
				
				
					Disturbance in attention: postmarketing nabilone
				
			nalmefene
				
			naltrexone
				
			naproxen
				
				
					Cerebration impaired: postmarketing nelarabine
				
			nicotine
				
			nifedipine
				
			nilotinib
				
				
					Disturbance in attention: uncommon oxcarbazepine
				
				
					Disturbance in attention: common Cerebration impaired: 2% paliperidone
				
			paroxetine
				
				
					Disturbance in attention: 0.3% Cerebration impaired: infrequent, common, frequent, 0.6% - 4.3% posaconazole
				
			pramipexole
				
			pregabalin
				
				
					Disturbance in attention: 1.4% - 5% Cerebration impairedprogesterone
				
			quetiapine
				
				
					Disturbance in attention: 2% raltegravir
				
				
					Disturbance in attentionCerebration impairedramipril
				
			retigabine
				
				
					Disturbance in attention: 6% - 7% ribavirin
				
				
					Disturbance in attention: common Cerebration impaired: common, very common, 5% - 21% rifampicin
				
			rifaximin
				
			rimantadine
				
				
					Cerebration impaired: 2.1% rimonabant
				
				
					Disturbance in attention: postmarketing risperidone
				
				
					Disturbance in attention: 0.9% - 4% Cerebration impaired: infrequent, 0% - 2% ritonavir
				
			rivastigmine
				
				
					Cerebration impaired: infrequent rizatriptan
				
			ropinirole
				
				
					Disturbance in attention: infrequent Cerebration impaired: infrequent, frequent, 2% rufinamide
				
				
					Disturbance in attention: 3% scopolamine
				
				
					Disturbance in attention: postmarketing sertraline
				
				
					Disturbance in attention: postmarketing Cerebration impaired: common sibutramine
				
			sitaxsentan
				
			sofosbuvir
				
				
					Disturbance in attention: common tapentadol
				
				
					Disturbance in attention: 1% tegaserod
				
			telithromycin
				
			temozolomide
				
				
					Cerebration impaired: common, 1% - 3% testosterone
				
			tiagabine
				
				
					Cerebration impaired: 6% - 14% Attention concentration difficultytopiramate
				
				
					Disturbance in attention: 2.6% - 11.9% Cerebration impaired: postmarketing, 0% - 15% Attention concentration difficulty: postmarketing tramadol
				
				
					Disturbance in attention: postmarketing, uncommon Cerebration impairedtrazodone
				
			tropicamide
				
			trovafloxacin
				
			v 1784
				
				
					Cerebration impaired: postmarketing valproate
				
			varenicline
				
				
					Disturbance in attention: frequent vigabatrin
				
				
					Disturbance in attention: common, 0% - 9% Cerebration impairedzalcitabine
				
			zaleplon
				
			ziconotide
				
			ziprasidone
				
				
					Disturbance in attention: uncommon zolpidem
				
				
					Disturbance in attention: 2% Cerebration impairedzonisamide
				
			zuclopenthixol
				
			 |